Home › Therapeutic areas › Antihyperlipidemic agents
Japan market screening · Therapeutic class
高脂血症用剤 · Japan Standard Commodity Classification
22 molecules in this class are marketed in Japan across 302 products. 34 of those products are not shipping normally today — 11.3% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.
Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.
| Molecule | Products | Companies | Constrained | Supply mix |
|---|---|---|---|---|
| Pitavastatin Calciumピタバスタチンカルシウム | 80 | 21 | 5 | |
| Rosuvastatin Calciumロスバスタチンカルシウム | 63 | 20 | 13 | |
| Atorvastatin Calcium Hydrateアトルバスタチンカルシウム水和物 | 34 | 16 | — | |
| Pravastatin Sodiumプラバスタチンナトリウム | 28 | 13 | 6 | |
| Simvastatinシンバスタチン | 22 | 8 | 3 | |
| Ezetimibeエゼチミブ | 19 | 18 | — | |
| Bezafibrateベザフィブラート | 12 | 6 | 1 | |
| Fluvastatin Sodiumフルバスタチンナトリウム | 9 | 3 | 3 | |
| Ezetimibe / Rosuvastatin Calciumエゼチミブ・ロスバスタチンカルシウム | 6 | 3 | — | |
| Fenofibrateフェノフィブラート | 6 | 3 | — | |
| Ezetimibe / Atorvastatin Calcium Hydrateエゼチミブ・アトルバスタチンカルシウム水和物 | 4 | 2 | 1 | |
| Lomitapide Mesilateロミタピドメシル酸塩 | 3 | 1 | — | |
| Pemafibrateペマフィブラート | 3 | 1 | — | |
| Probucolプロブコール | 3 | 3 | 1 | |
| Colestimideコレスチミド | 2 | 1 | — | |
| Pitavastatin Calcium Hydrate / Ezetimibeピタバスタチンカルシウム水和物・エゼチミブ | 2 | 1 | — | |
| Bempedoic Acidベムペド酸 | 1 | 1 | — | |
| Clofibrateクロフィブラート | 1 | 1 | 1 | |
| Colestyramineコレスチラミン | 1 | 1 | — | |
| Evinacumab (Genetical Recombination)エビナクマブ（遺伝子組換え） | 1 | 1 | — | |
| Evolocumab (Genetical Recombination)エボロクマブ（遺伝子組換え） | 1 | 1 | — | |
| Inclisiran Sodiumインクリシランナトリウム | 1 | 1 | — |
Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.
Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.
Send an enquiryOur Database Division replies in English within three business days (Japan time).
